Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial

Introduction: ACT DMD was a 48‐week trial of ataluren for nonsense mutation Duchenne muscular dystrophy (nmDMD). Patients received corticosteroids for ≥6 months at entry and stable regimens throughout study. This post hoc analysis compares efficacy and safety for deflazacort and prednisone/prednisol...

Descripción completa

Detalles Bibliográficos
Autores principales: Shieh, Perry B., Mcintosh, Joseph, Jin, Fengbin, Souza, Marcio, Elfring, Gary, Narayanan, Siva, Trifillis, Panayiota, Peltz, Stuart W., Mcdonald, Craig M., Darras, Basil T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767037/
https://www.ncbi.nlm.nih.gov/pubmed/30028519
http://dx.doi.org/10.1002/mus.26191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767037/
https://www.ncbi.nlm.nih.gov/pubmed/30028519
http://dx.doi.org/10.1002/mus.26191

Ejemplares similares